EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A novel diagnostic model for early-stage high-grade serous ovarian cancer based on serum tRNA-derived fragments

Xueyuan Zhao iD, Weijia Wen, Yan Jia, Li Yuan, Linna Chen, Songlin Liu, Haolin Fan, Hongye Jiang, Chaoyun Pan, Chunyu Zhang, Shuzhong Yao

Cancer Biomarkers · 2026-06 · 43

DOI: 10.1177/18758592261463300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biomarkers, online erschienen am 10.07.2026. Verfasst von Xueyuan Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P.R. China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, RNA, Transfer, Biomarkers, Tumor, Cystadenocarcinoma, Serous. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the National Key R&D Program of China, Basic and Applied Basic Research Foundation of Guangdong Province, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early detection of ovarian cancer, particularly high-grade serous ovarian cancer (HGSOC), remains challenging due to the lack of reliable biomarkers. This study investigated the potential of tRNA-derived small RNAs (tsRNAs) as non-invasive diagnostic biomarkers using liquid biopsy. Using qRT-PCR, we analyzed the relative Ct values of selected tsRNAs in plasma samples from healthy controls and patients with early- and late-stage HGSOC. A logistic regression model constructed using the relative Ct value of the selected tsRNA demonstrated high sensitivity and specificity for distinguishing ovarian cancer patients from healthy controls, including those with early-stage disease. The model was validated in a multi-center cohort, and analysis confirmed the dysregulation of this tsRNA in tumor tissue compared to normal tissue. These findings suggest that this single plasma tsRNA may serve as a promising biomarker for early HGSOC detection, supporting its potential clinical utility pending further mechanistic studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsRNA, TransferBiomarkers, TumorCystadenocarcinoma, SerousHumansFemaleNeoplasm StagingEarly Detection of CancerNeoplasm GradingMiddle AgedAged

Stichwörter der Autor:innen

diagnosticmolecular biomarkersovarian cancer

Substanzen

RNA, TransferBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P.R. China.
  • Guangdong Provincial Clinical Research Center for Obstetrical and Gynecological Diseases, Guangzhou, Guangdong, P.R. China.
  • Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, P.R. China.

ORCID-Profile: Xueyuan Zhao

Förderung

  • the National Key R&D Program of China
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Guangdong Medical Science and Technology Research Foundation
  • Science and Technology Plan of Guangdong Province
  • Guangzhou Science and Technology Program
  • Sun Yat-sen University Clinical Research Foundation of 5010 Project

Zitieren

APA

Zhao, X., Wen, W., Jia, Y., Yuan, L., Chen, L., Liu, S., Fan, H., Jiang, H., Pan, C., Zhang, C., & Yao, S. (2026). A novel diagnostic model for early-stage high-grade serous ovarian cancer based on serum tRNA-derived fragments. Cancer Biomarkers, 43. https://doi.org/10.1177/18758592261463300

Vancouver

Zhao X, Wen W, Jia Y, Yuan L, Chen L, Liu S, et al. A novel diagnostic model for early-stage high-grade serous ovarian cancer based on serum tRNA-derived fragments. Cancer Biomarkers. 2026;43. doi:10.1177/18758592261463300

BibTeX
@article{Zhao2026,
  author = {Zhao, Xueyuan and Wen, Weijia and Jia, Yan and Yuan, Li and Chen, Linna and Liu, Songlin and Fan, Haolin and Jiang, Hongye and Pan, Chaoyun and Zhang, Chunyu and Yao, Shuzhong},
  title = {A novel diagnostic model for early-stage high-grade serous ovarian cancer based on serum tRNA-derived fragments},
  journal = {Cancer Biomarkers},
  year = {2026},
  volume = {43},
  doi = {10.1177/18758592261463300}
}
Kostenlos starten →